Honors & Awards

  • Fulbright grant, Fulbright (2018)
  • Best case of radiologic pathology correlation, AIRP (2013)
  • Invest in the Youth, European Society of Radiology (2012)

Professional Education

  • Bachelor, Lycee Henri IV (2002)
  • MSc, Universite de Paris V (Rene Descartes), Biomedical Imaging (2012)
  • MD, Universite de Paris V (Rene Descartes), Medicine (2014)
  • PhD, Universite de Paris V (Rene Descartes), Imaging (2018)

Stanford Advisors


Graduate and Fellowship Programs


All Publications

  • Hemorrhagic transformation after stroke: Interrater and intrarater agreement. European journal of neurology Guenego, A., Lecler, A., Raymond, J., Sabben, C., Khoury, N., Premat, K., Botta, D., Boisseau, W., Maïer, B., Ciccio, G., Redjem, H., Smajda, S., Ducroux, C., Di Meglio, L., Davy, V., Olivot, J. M., Wang, A., Duplantier, J., Roques, M., Krystal, S., Koskas, P., Collin, A., Ben Maacha, M., Hamdani, M., Zuber, K., Blanc, R., Piotin, M., Fahed, R. 2018


    Hemorrhagic transformation (HT) is a complication of stroke that can occur spontaneously or after treatment. We aimed to assess the interrater and intrarater reliability of HT diagnosis.Studies assessing the reliability of the European Cooperative Acute Stroke Study (ECASS) classification of HT or of the presence (yes/no) of HT were systematically reviewed. Eighteen raters independently examined 30 post-thrombectomy computed tomography scans selected from the Aspiration versus Stentriever (ASTER) trial. They were asked whether there was HT (yes/no), what the ECASS classification of the particular scan (0/HI1/HI2/PH1/PH2) was, and whether they would prescribe an antiplatelet agent if it was otherwise indicated. Agreement was measured with Fleiss' and Cohen's kappa statistics.The systematic review yielded 4 studies involving few (?3) raters with heterogeneous results. In our 18-rater study, agreement for the presence of HT was moderate (?=0.55, 95%CI [0.41-0.68]). Agreement for ECASS classification was only fair for all 5 categories, but agreement improved to substantial (k=0.72, 95%CI [0.69-0.75]) after dichotomizing ECASS into 0/HI1/HI2/PH1 versus PH2. The interrater agreement for the decision to reintroduce antiplatelet therapy was moderate for all raters, but substantial among vascular neurologists (?=0.70 [0.57-0.84]).The ECASS classification may involve too many categories and the diagnosis of HT may not be easily replicable, except in the presence of a large parenchymal hematoma. This article is protected by copyright. All rights reserved.

    View details for DOI 10.1111/ene.13859

    View details for PubMedID 30414302

  • Central nervous system Aquaporin4 autoimmunity revealed by a single pseudotumoral encephalic lesion. Metabolic brain disease Fargeot, G., Aboab, J., Savatovsky, J., Marignier, R., Lecler, A., Gout, O. 2018; 33 (1): 353?55


    The radiological spectrum of neuromyelitis optica has become broader since the detection of aquaporin4 antibodies. We report a case of neuromyelitis optica patient with pseudotumoral encephalic lesion. A 66 year-old woman presented with sudden left lateral homonymous hemianopsia. A brain MRI showed an isolated and extensive right temporo-parieto-occipital lesion, involving periventricular white matter and the corpus callosum, with strong enhancement on post-gadolinium T1 weighted images, highly suggestive of lymphoma. Spinal cord MRI and body CT scan were unremarkable. Lumbar puncture showed pleocytosis, raised total protein level without abnormal cells or oligoclonal bands. A brain biopsy demonstrated non-specific demyelination. Serum aquaporin4 antibodies were positive, which was consistent with the diagnosis of neuromyelitis optica. Cases of central nervous system aquaporin4 autoimmunity presenting with an isolated brain lesion without optic neuritis or myelitis are extremely rare: this is the second case so far and the first one with advanced magnetic resonance characterization. Pseudotumoral encephalic lesions should include a large differential diagnosis, and testing aquaporin4 antibodies must be considered in order to avoid brain biopsy.

    View details for DOI 10.1007/s11011-017-0141-y

    View details for PubMedID 29090380

  • DWI-ASPECTS (Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Scores) and DWI-FLAIR (Diffusion-Weighted Imaging-Fluid Attenuated Inversion Recovery) Mismatch in Thrombectomy Candidates: An Intrarater and Interrater Agreement Study. Stroke Fahed, R., Lecler, A., Sabben, C., Khoury, N., Ducroux, C., Chalumeau, V., Botta, D., Kalsoum, E., Boisseau, W., Duron, L., Cabral, D., Koskas, P., Benaïssa, A., Koulakian, H., Obadia, M., Maïer, B., Weisenburger-Lile, D., Lapergue, B., Wang, A., Redjem, H., Ciccio, G., Smajda, S., Desilles, J. P., Mazighi, M., Ben Maacha, M., Akkari, I., Zuber, K., Blanc, R., Raymond, J., Piotin, M. 2018; 49 (1): 223?27


    We aimed to study the intrarater and interrater agreement of clinicians attributing DWI-ASPECTS (Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Scores) and DWI-FLAIR (Diffusion-Weighted Imaging-Fluid Attenuated Inversion Recovery) mismatch in patients with acute ischemic stroke referred for mechanical thrombectomy.Eighteen raters independently scored anonymized magnetic resonance imaging scans of 30 participants from a multicentre thrombectomy trial, in 2 different reading sessions. Agreement was measured using Fleiss ? and Cohen ? statistics.Interrater agreement for DWI-ASPECTS was slight (?=0.17 [0.14-0.21]). Four raters (22.2%) had a substantial (or higher) intrarater agreement. Dichotomization of the DWI-ASPECTS (0-5 versus 6-10 or 0-6 versus 7-10) increased the interrater agreement to a substantial level (?=0.62 [0.48-0.75] and 0.68 [0.55-0.79], respectively) and more raters reached a substantial (or higher) intrarater agreement (17/18 raters [94.4%]). Interrater agreement for DWI-FLAIR mismatch was moderate (?=0.43 [0.33-0.57]); 11 raters (61.1%) reached a substantial (or higher) intrarater agreement.Agreement between clinicians assessing DWI-ASPECTS and DWI-FLAIR mismatch may not be sufficient to make repeatable clinical decisions in mechanical thrombectomy. The dichotomization of the DWI-ASPECTS (0-5 versus 0-6 or 0-6 versus 7-10) improved interrater and intrarater agreement, however, its relevance for patients selection for mechanical thrombectomy needs to be validated in a randomized trial.

    View details for DOI 10.1161/STROKEAHA.117.019508

    View details for PubMedID 29191851

  • Optic Nerve Meningioma Mimicking Cavernous Hemangioma. World neurosurgery Savignac, A., Lecler, A. 2018; 110: 301?2


    A 38-year-old woman presented with rapidly worsening, painless right monocular vision loss. An examination revealed a visual acuity of 1.4/10 and a central scotoma in the right eye. The orbital magnetic resonance imaging (MRI) showed a well-delineated ovoid intraconal mass of the right eye, hyperintense on T2-weighted MRI with homogenous enhancement after contrast injection. The mass abutted and displaced the optic nerve. A diagnosis of cavernous hemangioma was evoked, which is the most common benign adult orbital mass with these MRI features. A biopsy was performed, and the histopathologic examination yielded a diagnosis of optic nerve sheath meningioma based on a positive antiprogesterone receptor antibody immunostaining. Our case highlights the problem with establishing a specific pathologic diagnosis based on MRI alone, even though the morphologic aspect is evocative. It is recommended to always conduct a histopathologic examination before establishing a specific diagnosis as pathology remains the gold standard, especially when the course of action or treatment may change, as in our case.

    View details for DOI 10.1016/j.wneu.2017.11.107

    View details for PubMedID 29191527

  • Rituximab for corticosteroid-resistant relapsing IgG4-related intracranial pachymeningitis: report of two cases. Practical neurology Mageau, A., Shor, N., Fisselier, M., Aboab, J., Lecler, A., Rebours, C., Adle-Biassette, H., Gout, O., Deschamps, R. 2018; 18 (2): 159?61


    IgG4-related disease is now recognised as an important cause of intracranial and spinal hypertrophic pachymeningitis. Treatment with corticosteroids generally leads to significant clinical improvement. We present two cases of IgG4 pachymeningitis unresponsive to corticosteroids who improved with rituximab.

    View details for DOI 10.1136/practneurol-2017-001826

    View details for PubMedID 29208730

  • Multiparametric Imaging Improves Confidence in the Diagnosis of Multinodular and Vacuolating Neuronal Tumor of the Cerebrum. AJNR. American journal of neuroradiology Lecler, A., Chauvet, D., Biassette, H. A., Savatovsky, J. 2018; 39 (2): E32?E33

    View details for DOI 10.3174/ajnr.A5425

    View details for PubMedID 29051207

  • In Response to the Letter to the Editor Regarding "Optic Nerve Meningioma Mimicking Cavernous Hemangioma". World neurosurgery Lecler, A., Savignac, A. 2018; 111: 436

    View details for DOI 10.1016/j.wneu.2017.12.128

    View details for PubMedID 29288857

  • Ophthalmic artery MRI in an arteritis-related central retinal artery occlusion. Neurology Weisenburger-Lile, D., Obadia, M., Cahuzac, A., Lecler, A. 2018; 90 (4): 188?89

    View details for DOI 10.1212/WNL.0000000000004864

    View details for PubMedID 29358510

  • Teaching NeuroImages: A diffuse infiltrating retinoblastoma. Neurology Friang, C., Caputo, G., Freneaux, P., Lecler, A. 2018; 90 (4): e357?e358

    View details for DOI 10.1212/WNL.0000000000004855

    View details for PubMedID 29358521

  • Infraorbital Nerve Involvement on Magnetic Resonance Imaging in Igg4-Related Ophthalmic Disease: A Highly Suggestive Sign. Ophthalmology Lecler, A., Zmuda, M., Deschamps, R. 2018; 125 (4): 577

    View details for DOI 10.1016/j.ophtha.2017.12.025

    View details for PubMedID 29566870

  • Increasing the Accuracy of Optic Nerve Measurement Using 3D Volumetry. AJNR. American journal of neuroradiology Lecler, A., Savatovsky, J., Lamirel, C. 2018; 39 (6): E80

    View details for DOI 10.3174/ajnr.A5625

    View details for PubMedID 29650779

  • Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy. European radiology Lecler, A., Charbonneau, F., Psimaras, D., Metten, M. A., Gueguen, A., Hoang Xuan, K., Feuvret, L., Savatovsky, J. 2018; 28 (10): 4324?33


    To evaluate the prevalence of cerebral remote microhaemorrhages (RMH) and remote haematomas (RH) using magnetic resonance susceptibility-weighted imaging (SWI) among patients treated for gliomas during follow-up.We conducted a retrospective single centre longitudinal study on 58 consecutive patients treated for gliomas from January 2009 through December 2010. Our institutional review board approved this study. We evaluated the presence and number of RMH and RH found outside the brain tumour on follow-up MR imaging. We performed univariate and bivariate analyses to identify predictors for RMH and RH and Kaplan-Meier survival analysis techniques.Twenty-five (43%) and four patients (7%) developed at least one RMH or RH, respectively, during follow-up. The risk was significantly higher for patients who received radiation therapy (49% and 8% versus 0%) (p = 0.02). The risk of developing RH was significantly higher in patients with at least one RMH and a high burden of RMH. The mean age of those presenting with at least one RMH or RH was significantly lower.RMH were common in adult survivors of gliomas who received radiation therapy and may predict the onset of RH during follow-up, mainly in younger patients.? Brain RMH and RH are significantly more likely to occur after RT. ? RMH occur in almost half of the patients treated with RT. ? RMH and RH are significantly more frequent in younger patients. ? RH occur only in patients with RMH.

    View details for DOI 10.1007/s00330-018-5356-8

    View details for PubMedID 29651771

  • Application of the DAWN clinical imaging mismatch and DEFUSE 3 selection criteria: benefit seems similar but restrictive volume cut-offs might omit potential responders. European journal of neurology Ducroux, C., Khoury, N., Lecler, A., Blanc, R., Chetrit, A., Redjem, H., Ciccio, G., Smajda, S., Escalard, S., Desilles, J. P., Mazighi, M., Ben Maacha, M., Piotin, M., Fahed, R. 2018; 25 (8): 1093?99


    An external validation of the selection criteria of diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake-up and late-presenting strokes undergoing the Neurointervention with Trevo (DAWN) and the Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke (DEFUSE3) trials was conducted in a cohort of unknown onset stroke (UOS) patients treated with thrombectomy.A validation cohort of UOS patients was selected from a prospectively collected thrombectomy database to match the inclusion criteria of DAWN and DEFUSE 3. Patients with an initial National Institutes of Health Stroke Scale (NIHSS) ?10 were stratified according to the DAWN selection criteria. Patients ?90 years old with an initial NIHSS ?6 were stratified according to the DEFUSE 3 selection criteria. The proportions of patients with a modified Rankin Scale (mRS) ?2 at 3 months follow-up were compared between DAWN-eligible patients and the DAWN trial thrombectomy group, and between DEFUSE 3-eligible patients and the DEFUSE 3 trial thrombectomy group.Of the 60/102 (59%) DAWN-eligible patients, 26 patients (43%) reached a mRS ?2 at 3 months follow-up [versus 52/107 patients (49%) in the DAWN trial thrombectomy group; P = 0.52]. Of the 100/117 (85%) DEFUSE 3-eligible patients, 48 patients (48%) reached a mRS ?2 at 3 months follow-up [versus 41/92 patients (45%) in the DEFUSE 3 trial thrombectomy group; P = 0.67]. Of the DAWN-ineligible and DEFUSE 3-ineligible patients who underwent thrombectomy, 38% (16/42) and 41% (7/17) of patients reached a mRS ?2, respectively.The results of the DAWN and DEFUSE 3 trials were externally validated in a UOS cohort where the trials' selection criteria identified a similar proportion of responders to thrombectomy.

    View details for DOI 10.1111/ene.13660

    View details for PubMedID 29667266

  • Traumatic Optic Nerve Transection. JAMA ophthalmology Lecler, A., Savatovsky, J., Cahuzac, A. 2018; 136 (5): e180490

    View details for DOI 10.1001/jamaophthalmol.2018.0490

    View details for PubMedID 29800253

  • Introduction of the TIPIC syndrome in the next ICHD classification. Cephalalgia : an international journal of headache Lecler, A., Obadia, M., Sadik, J. C. 2018: 333102418780485

    View details for DOI 10.1177/0333102418780485

    View details for PubMedID 29807466

  • Improved Detection of New MS Lesions during Follow-Up Using an Automated MR Coregistration-Fusion Method. AJNR. American journal of neuroradiology Galletto Pregliasco, A., Collin, A., Guéguen, A., Metten, M. A., Aboab, J., Deschamps, R., Gout, O., Duron, L., Sadik, J. C., Savatovsky, J., Lecler, A. 2018; 39 (7): 1226?32


    MR imaging is the key examination in the follow-up of patients with MS, by identification of new high-signal T2 brain lesions. However, identifying new lesions when scrolling through 2 follow-up MR images can be difficult and time-consuming. Our aim was to compare an automated coregistration-fusion reading approach with the standard approach by identifying new high-signal T2 brain lesions in patients with multiple sclerosis during follow-up MR imaging.This prospective monocenter study included 94 patients (mean age, 38.9 years) treated for MS with dimethyl fumarate from January 2014 to August 2016. One senior neuroradiologist and 1 junior radiologist checked for new high-signal T2 brain lesions, independently analyzing blinded image datasets with automated coregistration-fusion or the standard scroll-through approach with a 3-week delay between the 2 readings. A consensus reading with a second senior neuroradiologist served as a criterion standard for analyses. A Poisson regression and logistic and ? regressions were used to compare the 2 methods. Intra- and interobserver agreement was assessed by the ? coefficient.There were significantly more new high-signal T2 lesions per patient detected with the coregistration-fusion method (7 versus 4, P < .001). The coregistration-fusion method detected significantly more patients with at least 1 new high-signal T2 lesion (59% versus 46%, P = .02) and was associated with significantly faster overall reading time (86 seconds faster, P < .001) and higher reader confidence (91% versus 40%, P < 1 × 10-4). Inter- and intraobserver agreement was excellent for counting new high-signal T2 lesions.Our study showed that an automated coregistration-fusion method was more sensitive for detecting new high-signal T2 lesions in patients with MS and reducing reading time. This method could help to improve follow-up care.

    View details for DOI 10.3174/ajnr.A5690

    View details for PubMedID 29880479

  • Acute idiopathic optic neuritis: not always benign. European journal of neurology Deschamps, R., Gueguen, A., Lecler, A., Lecouturier, K., Lamirel, C., Bensa, C., Marignier, R., Vignal, C., Gout, O. 2018; 25 (11): 1378?83


    Few recent data are available concerning idiopathic optic neuritis (ON). We aimed to describe a large cohort of patients with idiopathic ON. We compared this cohort with patients with ON related to myelin oligodendrocyte glycoprotein (MOG) or ON related to aquaporin-4 (AQP4) antibodies.This was a monocentric retrospective observational study. Inclusion criteria for idiopathic ON were as follows: age ? 16 years, follow-up of at least 2 years, negative for antibodies against MOG and AQP4 immunoglobulin G, and no magnetic resonance imaging (MRI) lesions suggestive of demyelination (two brain MRI scans, one at baseline and one during follow-up, and one spinal cord MRI scan).Among 23 patients with idiopathic ON (female, 82.6%; median age, 36 years; median follow-up time, 41.4 months), 56.5% had recurrent ON (median time to a second ON episode, 6 months). The final visual acuity in this group (median, 0; mean, 0.43; range, 0-3) was similar to that in the AQP4 group (n = 18; P-value after Bonferroni correction = 0.936) but worse than that in the MOG group (n = 25; P-value after Bonferroni correction = 0.019). At the last evaluation, visual acuity levels were ?0.5 and <0.2, respectively, in 36.8% and 21% of the idiopathic ON group, 58.3% and 26.7% of the AQP4 group, and 0% and 0% of the MOG group.The recovery of visual acuity among patients with idiopathic ON was poor, similar to that observed in the AQP4 group.

    View details for DOI 10.1111/ene.13753

    View details for PubMedID 30004610

  • Lacrimal Gland Ischemia due to Giant Cell Arteritis. Ophthalmology Heraud, A., Zmuda, M., Lecler, A. 2018; 125 (8): 1233

    View details for DOI 10.1016/j.ophtha.2018.04.032

    View details for PubMedID 30032795

  • MRI findings in orbital infarction syndrome. Revue neurologique Fargeot, G., Lecler, A., Lamirel, C., Savatovsky, J., Obadia, M. 2018; 174 (7-8): 571?73

    View details for DOI 10.1016/j.neurol.2017.07.015

    View details for PubMedID 30049561

  • Quality-Control Assessment to Improve the Accuracy of Dynamic Contrast-Enhanced MR Imaging Perfusion. AJNR. American journal of neuroradiology Lecler, A., Sadik, J. C., Savatovsky, J. 2018; 39 (10): E107

    View details for DOI 10.3174/ajnr.A5787

    View details for PubMedID 30213817

  • Is the Association of Retinal Venous Malformations With Venous Malformations of the Brain Clinically Meaningful? JAMA ophthalmology Lecler, A., Duron, L., Savatovsky, J. 2018

    View details for DOI 10.1001/jamaophthalmol.2018.4050

    View details for PubMedID 30242319

  • Breast tissue density change after oophorectomy in BRCA mutation carrier patients using visual and volumetric analysis. The British journal of radiology Lecler, A., Dunant, A., Delaloge, S., Wehrer, D., Moussa, T., Caron, O., Balleyguier, C. 2018; 91 (1083): 20170163


    BRCA1/2 mutations account for 30-50% of hereditary breast cancers and bilateral oophorectomy is associated with a reduced risk of breast cancer in these patients. Breast density is a well-established breast cancer risk factor and is also associated with increased risk in BRCA carriers. The aim of the study was to evaluate the impact of oophorectomy on mammographic breast density and to assess which method of breast density assessment is more sensitive to change over time.Retrospective study of 50 BRCA1/2 patients who underwent bilateral oophorectomy and had at least a baseline and post-surgery mammogram. Mammographic breast density was determined by Volpara and consensus visual assessment by two radiologists. The primary endpoint was change in density between baseline and the first mammogram post-surgery.At baseline, there was a non-significant trend for decreased density with increasing age. Volumetric breast density (VBD) significantly decreased after oophorectomy from a median VBD of 12.5% at baseline to 10.2% post-surgery which was driven by a reduction in fibroglandular volume. There was a higher absolute decrease in VBD in patients aged between 40-50 (p < 0.01). Using Volpara Density Grades (analogous to BI-RADS 4th edition density categories), 84% of females displayed a decrease in density category over the study period compared to only 76% using the radiologists' visual classification (p < 0.001) Conclusion: Oophorectomy is associated with a decrease in breast density and younger patients exhibit a larger absolute decrease. Volpara is more sensitive to identify change over time compared to visual assessment. Advances in knowledge: Oophorectomy is associated with a significant decrease in VBD in patients with BRCA mutations and Volpara Density Grades were more sensitive to identify decreases in density compared to visually assessed BI-RADS categories. Decreases in breast density following oophorectomy surgery in BRCA patients may be one of the mechanisms contributing to the observed decreased breast cancer risk after surgery. However, further studies are needed to investigate the relationship between breast density, oophorectomy and breast cancer risk in BRCA patients.

    View details for DOI 10.1259/bjr.20170163

    View details for PubMedID 29182397

    View details for PubMedCentralID PMC5965464

  • Track-weighted imaging for neuroretina: Evaluations in healthy volunteers and ischemic optic neuropathy. Journal of magnetic resonance imaging : JMRI Attyé, A., Jean, C., Remond, P., Peyrin, C., Lecler, A., Boudiaf, N., Aptel, F., Chiquet, C., Lamalle, L., Krainik, A. 2018


    The use of MRI-tractography to explore the human neuroretina is yet to be reported. Track-weighted imaging (TWI) was recently introduced as a qualitative tractography-based method with high anatomical contrast.To explore the human retina in healthy volunteers and patients with anterior ischemic optic neuropathy (AION) using TWI reconstructions.Prospective.Twenty AION patients compared with 20 healthy volunteers.3.0T MRI diffusion-weighted imaging (DWI) with b-value of 1000 s/mm2 and 60 diffusion-weighting noncollinear directions.We performed constrained spherical deconvolution from the diffusion-weighted signal and volumetric tractography method, whereby 10 million streamlines are initiated from seed points randomly distributed throughout the orbital area. We then reconstructed TWI maps with isotropic voxel size of 300 ?m.We tested the effect of the number of diffusion-weighting directions, ocular laterality, and ocular dominance on healthy retinal fascicles distribution. We then performed factorial analysis of variance to test the effects of the presence/absence of the fascicles on the visual field defect in patients.In healthy volunteers, we found more temporal fascicle in right eyes (P = 0.001), more superior fascicles in dominant eyes (P = 0.014), and fewer fascicles with tractography maps based on 30 directions than those based on 45 directions (P = 9 × 10-8 ) and 60 directions (P = 6 × 10-7 ). Eight out of 20 AION patients presented with complete absence of neuroretinal fascicle, side of the disease, which was correlated with visual field mean deviation at the 6-month visit [F(1,17) = 6.97, P = 0.016]. Seven patients presented with a temporal fascicle in the injured eye; this fascicle presence was linked to visual field mean deviation at the 6-month visit [F(1,17) = 8.43, P = 0.009].In AION patients, the presence of the temporal neuroretinal fascicle in the affected eye provides an objective outcome radiological sign correlated with visual performance.2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018.

    View details for DOI 10.1002/jmri.25941

    View details for PubMedID 29292557

  • Magnetic resonance post-contrast vascular hyperintensities at 3 T: a new highly sensitive sign of vascular occlusion in acute ischaemic stroke. European radiology Duron, L., Savatovsky, J., Obadia, M., Metten, M. A., Roux, P., Blanc, R., Sadik, J. C., Dhundass, S., Lecler, A. 2018; 28 (7): 2903?13


    Magnetic resonance imaging (MRI) is the diagnostic cornerstone for precisely identifying acute ischaemic strokes and locating vascular occlusions, especially since mechanical thrombectomy has become a reference treatment. We observed that a post-contrast three-dimensional turbo-spin-echo T1-weighted sequence showed striking post-contrast vascular hyperintensities (PCVH) in ischaemic territories. We aimed to evaluate the prevalence and the meaning of this finding.This retrospective single centre study included 130 consecutive patients admitted for acute ischaemic stroke with a 3-T MRI performed in the first 12 h of symptom onset from September 2014 through September 2016. Two neuroradiologists blinded to clinical data analysed the first MRI assessments. The association between PCVH and clinical, radiological and follow-up findings was assessed, as well as inter- and intra-observer agreements.Of 130 patients, 105 (81%) had PCVH in the ischaemic territory. PCVH were associated with the presence of thrombus on susceptibility weighted imaging (p < 0.0001) and vascular occlusions on MR angiography (p < 0.0001). All patients with a visible thrombus had PCVH closely surrounding the clot. PCVH were associated with higher initial (p < 0.01) and follow-up (p < 0.01) National Institutes of Health Stroke Scale score, and higher mRS score (p < 0.05). Thrombectomy was the reference treatment for all patients with arterial occlusions. Inter- and intra-observer agreements for the detection of PCVH were excellent (? = 0.95 and ? = 0.91, respectively).PCVH during acute strokes are a striking sensitive and reproducible tool for diagnosing and locating vascular occlusions. It may help triage patients who can benefit from thrombectomy.? Post-contrast vascular hyperintensities (PCVH) are a sensitive MR finding in acute stroke ? PCVH are strongly associated with the presence and location of arterial occlusions ? Inter- and intra-observer agreements for the detection of PCVH are excellent ? PCVH are visible even in the case of significant motion artefacts ? PCVH may help triage patients who can benefit from mechanical thrombectomy.

    View details for DOI 10.1007/s00330-018-5312-7

    View details for PubMedID 29426989

  • Re: Chang et al.: Accuracy of diagnostic imaging modalities for classifying pediatric eyes as papilledema versus pseudopapilledema (Ophthalmology. 2017;124:1839-1848). Ophthalmology Lecler, A., Gillard, P. 2018; 125 (3): e23

    View details for DOI 10.1016/j.ophtha.2017.09.025

    View details for PubMedID 29458838

  • Congenital Achiasma. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society Lecler, A., Attye, A., Edelson, C. 2018; 38 (3): 344?46


    In evaluating a 3-month-old boy with horizontal nystagmus, brain MRI revealed absence of the optic chiasm. The remainder of the brain was normal in appearance. Achiasma was confirmed with diffusion tensor imaging and best visualized with optimized probabilistic-based tractography.

    View details for DOI 10.1097/WNO.0000000000000650

    View details for PubMedID 29561327

  • Rosette-Forming Glioneuronal Tumor of Spinal Cord. World neurosurgery Collin, A., Adle-Biassette, H., Lecler, A. 2018; 119: 242?43


    Rosette-forming glioneuronal tumor has recently been included in the World Health Organization classification as a low-grade tumor. It usually occurs in young adults, arising from the fourth ventricular region. The authors describe a rare case of rosette-forming glioneuronal tumor arising from the spinal cord with cerebrospinal fluid dissemination. Magnetic resonance imaging showed a cervical spinal cord tumor, which could be easily misdiagnosed as ependyma or astrocytoma. Surgical total resection was performed, and histopathologic examination made the diagnosis, showing a biphasic neurocytic and glial tumor with neurocytic rosettes. Six months after surgery, the patient had fully recovered.

    View details for DOI 10.1016/j.wneu.2018.08.035

    View details for PubMedID 30121405

  • Teaching NeuroImages: Morning glory disc anomaly. Neurology Poillon, G., Gillard, P., Lecler, A. 2018; 91 (15): e1457?e1458

    View details for DOI 10.1212/WNL.0000000000006325

    View details for PubMedID 30297511

  • The Central Bright Spot Sign: A Potential New MR Imaging Sign for the Early Diagnosis of Anterior Ischemic Optic Neuropathy due to Giant Cell Arteritis. AJNR. American journal of neuroradiology Remond, P., Attyé, A., Lecler, A., Lamalle, L., Boudiaf, N., Aptel, F., Krainik, A., Chiquet, C. 2017; 38 (7): 1411?15


    A rapid identification of the etiology of anterior ischemic optic neuropathy is crucial because it determines therapeutic management. Our aim was to assess MR imaging to study the optic nerve head in patients referred with anterior ischemic optic neuropathy, due to either giant cell arteritis or the nonarteritic form of the disease, compared with healthy subjects.Fifteen patients with giant cell arteritis-related anterior ischemic optic neuropathy and 15 patients with nonarteritic anterior ischemic optic neuropathy from 2 medical centers were prospectively included in our study between August 2015 and May 2016. Fifteen healthy subjects and patients had undergone contrast-enhanced, flow-compensated, 3D T1-weighted MR imaging. The bright spot sign was defined as optic nerve head enhancement with a 3-grade ranking system. Two radiologists and 1 ophthalmologist independently performed blinded evaluations of MR imaging sequences with this scale. Statistical analysis included interobserver agreement.MR imaging scores were significantly higher in patients with giant cell arteritis-related anterior ischemic optic neuropathy than in patients with nonarteritic anterior ischemic optic neuropathy (P ? .05). All patients with giant cell arteritis-related anterior ischemic optic neuropathy (15/15) and 7/15 patients with nonarteritic anterior ischemic optic neuropathy presented with the bright spot sign. No healthy subjects exhibited enhancement of the anterior part of the optic nerve. There was a significant relationship between the side of the bright spot and the side of the anterior ischemic optic neuropathy (P ? .001). Interreader agreement was good for observers (? = 0.815).Here, we provide evidence of a new MR imaging sign that identifies the acute stage of giant cell arteritis-related anterior ischemic optic neuropathy; patients without this central bright spot sign always had a nonarteritic pathophysiology and therefore did not require emergency corticosteroid therapy.

    View details for DOI 10.3174/ajnr.A5205

    View details for PubMedID 28495949

  • Usefulness of colour Doppler flow imaging in the management of lacrimal gland lesions. European radiology Lecler, A., Boucenna, M., Lafitte, F., Koskas, P., Nau, E., Jacomet, P. V., Galatoire, O., Morax, S., Putterman, M., Mann, F., Héran, F., Sadik, J. C., Picard, H., Bergès, O. 2017; 27 (2): 779?89


    To assess the role of colour Doppler flow imaging (CDFI) in the diagnosis and management of lacrimal fossa lesions.Institutional ethical committee approval was obtained. Fifty-one patients with 62 lacrimal fossa lesions were retrospectively included from 2003-2015. All patients underwent conventional ultrasonography and CDFI, with a qualitative and quantitative analysis of the vascularization. All patients had lacrimal gland surgery. Definitive diagnosis was based on pathological examination.The study included 47 non-epithelial lesions (NEL) and 15 epithelial lesions (EL), with 24 (39 %) malignant lesions and 38 (61 %) benign lesions. NEL were significantly more likely to present with septa (p?

    View details for DOI 10.1007/s00330-016-4438-8

    View details for PubMedID 27271920

  • Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign. European radiology Soussan, J. B., Deschamps, R., Sadik, J. C., Savatovsky, J., Deschamps, L., Puttermann, M., Zmuda, M., Heran, F., Galatoire, O., Picard, H., Lecler, A. 2017; 27 (4): 1335?43


    To measure the frequency of infraorbital nerve enlargement (IONE) on magnetic resonance imaging (MRI) in European patients suffering from an IgG4-related ophthalmic disease (IgG4-ROD) as compared to patients suffering from non-IgG4-related ophthalmic disease (non-IgG4-ROD).From January 2006 through April 2015, 132 patients were admitted for non-lymphoma, non-thyroid-related orbital inflammation. Thirty-eight had both pre-therapeutic orbital MRI and histopathological IgG4 immunostaining. Fifteen patients were classified as cases of IgG4-ROD and 23 patients as cases of non-IgG4-ROD. Two readers performed blinded analyses of MRI images. The main criterion was the presence of an IONE, defined as the infraorbital nerve diameter being greater than the optic nerve diameter in the coronal section.IONE was present in 53% (8/15) of IgG4-ROD cases whereas it was never present (0/23) in cases of non-IgG4-ROD (P < 0.0001). IONE was only present in cases where, on MRI, the inflammation of the inferior quadrant was present and in direct contact with the ION canal.In European patients suffering from orbital inflammation, the presence of IONE on an MRI is a specific sign of IgG4-ROD. Recognition of this pattern may facilitate the accurate diagnosis for clinicians and allow for the adequate management and appropriate care of their patients.? IONE on an MRI is a specific sign of IgG4-ROD. ? IONE recognition allows for a quicker diagnosis and appropriate management. ? IONE appears when inflammation is in direct contact with the ION canal.

    View details for DOI 10.1007/s00330-016-4481-5

    View details for PubMedID 27436015

  • Evisceration and ocular tumors: What are the consequences? Journal francais d'ophtalmologie Lemaître, S., Lecler, A., Lévy-Gabriel, C., Reyes, C., Desjardins, L., Gentien, D., Zmuda, M., Jacomet, P. V., Lumbroso-Le Rouic, L., Dendale, R., Vincent-Salomon, A., Pierron, G., Galatoire, O., Cassoux, N. 2017; 40 (2): 93?101


    Evisceration can be performed for blind, painful eyes. This surgery can promote the dissemination of tumor cells within the orbit if an ocular tumor has been missed preoperatively.We reviewed the medical records of patients who were eviscerated for blind, painful eyes between 2009 and 2014 and who were referred after the surgery to the Institut Curie or the Rothschild Foundation in Paris. We included the patients with a histological diagnosis of ocular tumor or orbital recurrence. Cytogenetic analysis was performed whenever possible.Four patients turned out to have an ocular tumor after evisceration (two choroidal melanomas, a rhabdoid tumor and an adenocarcinoma of the retinal pigment epithelium); two had a history of prior ocular trauma. The tumors were diagnosed either on histological analysis of the intraocular contents (2 patients) or biopsy of orbital recurrence (2 patients). Prior to evisceration, fundus examination was not performed in 3 patients. One had preoperative imaging but no intraocular tumor was suspected. At the time of this study, 3 patients had had an orbital recurrence and died. We also found 2 patients who had an evisceration despite a past history of choroidal melanoma treated with proton beam therapy.We showed that evisceration of eyes with unsuspected ocular malignancies was associated with a poor prognosis due to orbital recurrence and metastasis. The evisceration specimen should therefore always be sent for histological analysis in order to perform prompt adjuvant orbital radiotherapy if an ocular tumor is found.

    View details for DOI 10.1016/j.jfo.2016.10.007

    View details for PubMedID 28126270

  • Blood-Brain Barrier Leakage in Early Alzheimer Disease. Radiology Lecler, A., Fournier, L., Diard-Detoeuf, C., Balvay, D. 2017; 282 (3): 923?25

    View details for DOI 10.1148/radiol.2017162578

    View details for PubMedID 28218884

  • Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients. European journal of neurology Deschamps, R., Lecler, A., Lamirel, C., Aboab, J., Gueguen, A., Bensa, C., Vignal, C., Gout, O. 2017; 24 (6): 875?79


    New criteria for the diagnosis of multiple sclerosis (MS) and discovery of myelin oligodendrocyte glycoprotein (MOG) or aquaporin-4 (AQP4) antibodies (Abs) have changed the management of optic neuritis (ON). Our aim was to specify, in view of these recent advances, the etiologies of acute demyelinating ON for consecutive patients.Retrospective database analysis was undertaken of consecutive adult patients with acute ON admitted from 1 December 2014 to 31 January 2016. Diagnosis of MS was made according to the 2010 McDonald criteria. Patients with Abs to AQP4 or MOG were classified as ON-AQP4 and ON-MOG, respectively. Patients who did not fulfill the diagnostic criteria and were negative for AQP4 and MOG Ab tests were classified as having idiopathic ON.Of 110 patients assessed, 78 had ON related to MS (70.9%). All patients without MS were tested for AQP4 and MOG Abs: 11 had MOG Ab (10%), 5 had AQP4 Ab (4.5%) and 16 were considered as having idiopathic ON (14.5%). Presence of intrathecal IgG oligoclonal bands was strongly associated with MS (mean, 88.4% vs. 34.4% in patients without MS; after Bonferroni correction, P < 0.0001).Optic neuritis related to MOG Ab was the second cause identified of demyelinating ON in our center. Idiopathic ON was as frequent as both ON-AQP4 and ON-MOG combined.

    View details for DOI 10.1111/ene.13315

    View details for PubMedID 28477397

  • TIPIC Syndrome: Beyond the Myth of Carotidynia, a New Distinct Unclassified Entity. AJNR. American journal of neuroradiology Lecler, A., Obadia, M., Savatovsky, J., Picard, H., Charbonneau, F., Menjot de Champfleur, N., Naggara, O., Carsin, B., Amor-Sahli, M., Cottier, J. P., Bensoussan, J., Auffray-Calvier, E., Varoquaux, A., De Gaalon, S., Calazel, C., Nasr, N., Volle, G., Jianu, D. C., Gout, O., Bonneville, F., Sadik, J. C. 2017; 38 (7): 1391?98


    The differential diagnosis of acute cervical pain includes nonvascular and vascular causes such as carotid dissection, carotid occlusion, or vasculitis. However, some patients present with unclassified vascular and perivascular changes on imaging previously reported as carotidynia. The aim of our study was to improve the description of this as yet unclassified clinico-radiologic entity.From January 2009 through April 2016, 47 patients from 10 centers presenting with acute neck pain or tenderness and at least 1 cervical image showing unclassified carotid abnormalities were included. We conducted a systematic, retrospective study of their medical charts and diagnostic and follow-up imaging. Two neuroradiologists independently analyzed the blinded image datasets.The median patient age was 48 years. All patients presented with acute neck pain, and 8 presented with transient neurologic symptoms. Imaging showed an eccentric pericarotidian infiltration in all patients. An intimal soft plaque was noted in 16 patients, and a mild luminal narrowing was noted in 16 patients. Interreader reproducibility was excellent. All patients had complete pain resolution within a median of 13 days. At 3-month follow-up, imaging showed complete disappearance of vascular abnormalities in 8 patients, and a marked decrease in all others.Our study improved the description of an unclassified, clinico-radiologic entity, which could be described by the proposed acronym: TransIent Perivascular Inflammation of the Carotid artery (TIPIC) syndrome.

    View details for DOI 10.3174/ajnr.A5214

    View details for PubMedID 28495942

  • Coregistration and Fusion: An Easy and Reliable Method for Identifying Cranial Nerve IV on MRI. AJNR. American journal of neuroradiology Lecler, A., Savatovsky, J., Audren, F. 2017; 38 (10): E81?E82

    View details for DOI 10.3174/ajnr.A5286

    View details for PubMedID 28642267

  • Repeatability of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0 Tesla in orbital lesions. European radiology Lecler, A., Savatovsky, J., Balvay, D., Zmuda, M., Sadik, J. C., Galatoire, O., Charbonneau, F., Bergès, O., Picard, H., Fournier, L. 2017; 27 (12): 5094?5103


    To evaluate repeatability of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) parameters in the orbit.From December 2015 to March 2016, 22 patients were scanned twice using an IVIM sequence with 15b values (0-2,000 s/mm2) at 3.0T. Two readers independently delineated regions of interest in an orbital mass and in different intra-orbital and extra-orbital structures. Short-term test-retest repeatability and inter-observer agreement were assessed using the intra-class correlation coefficient (ICC), the coefficient of variation (CV) and Bland-Altman limits of agreements (BA-LA).Test-retest repeatability of IVIM parameters in the orbital mass was satisfactory for ADC and D (mean CV 12% and 14%, ICC 95% and 93%), poor for f and D*(means CV 43% and 110%, ICC 90% and 65%). Inter-observer repeatability agreement was almost perfect in the orbital mass for all the IVIM parameters (ICC = 95%, 93%, 94% and 90% for ADC, D, f and D*, respectively).IVIM appeared to be a robust tool to measure D in orbital lesions with good repeatability, but this approach showed a poor repeatability of f and D*.? IVIM technique is feasible in the orbit. ? IVIM has a good-acceptable repeatability of D (CV range 12-25 %). ? IVIM interobserver repeatability agreement is excellent (ICC range 90-95 %). ? f or D* provide higher test-retest and interobserver variabilities.

    View details for DOI 10.1007/s00330-017-4933-6

    View details for PubMedID 28677061

    View details for PubMedCentralID PMC5674133

  • Open Globe Injury: Ultrasound First! AJNR. American journal of neuroradiology Lecler, A., Pinel, A., Koskas, P. 2017; 38 (11): E99?E100

    View details for DOI 10.3174/ajnr.A5282

    View details for PubMedID 28818829

  • Risk Factors for Aneurysm Recurrence: Response Radiology Naggara, O. N., Edjlali, M., Ben Hassen, W., Lecler, A., Boulouis, G., Oppenheim, C. 2017; 283 (3): 919?20

    View details for DOI 10.1148/radiol.2017162628

    View details for PubMedID 29039898

  • Multinodular vacuolating and neuronal tumor of the cerebrum. Neurology Badat, N., Savatovsky, J., Charbonneau, F., Collin, A., Lecler, A. 2017; 89 (3): 304?5

    View details for DOI 10.1212/WNL.0000000000004123

    View details for PubMedID 28716873

  • TIPIC syndrome. Neurology Lecler, A., Obadia, M., Sadik, J. C. 2017; 89 (15): 1646?47

    View details for DOI 10.1212/WNL.0000000000004502

    View details for PubMedID 28993524

  • Atypical intracranial artifacts caused by dreadlocks during brain Magnetic Resonance Imaging: Keep calm and recognize them. Journal of neuroradiology. Journal de neuroradiologie Koulakian, H., Savatovsky, J., Breil, S., Sadik, J. C., Trunet, S., Lecler, A. 2017; 44 (1): 57?62

    View details for DOI 10.1016/j.neurad.2016.06.004

    View details for PubMedID 28341001

  • Response to characterization of orbital masses by multiparametric MRI. European journal of radiology Lecler, A., Balvay, D., Fournier, L. 2016; 85 (9): 1686?87

    View details for DOI 10.1016/j.ejrad.2016.06.018

    View details for PubMedID 27397419

  • Intracranial Aneurysms: Recurrences More than 10 Years after Endovascular Treatment-A Prospective Cohort Study, Systematic Review, and Meta-Analysis. Radiology Lecler, A., Raymond, J., Rodriguez-Régent, C., Al Shareef, F., Trystram, D., Godon-Hardy, S., Ben Hassen, W., Meder, J. F., Oppenheim, C., Naggara, O. N. 2015; 277 (1): 173?80


    To assess the efficacy of endovascular treatment (EVT) of intracranial aneurysms for recurrence, bleeding, and de novo aneurysm formation at long-term follow-up (> 10 years after treatment) with magnetic resonance (MR) angiography and to identify risk factors for recurrence through a prospective study and a systematic review of the literature.Clinical examinations and 3-T MR angiography were performed prospectively 10 years after EVT of intracranial aneurysms in a single institution. Ethics committee approval and informed consent were obtained. PubMed, EMBASE, and Cochrane databases were searched to identify studies in which authors reported bleeding and/or aneurysm recurrence rates in patients who received follow-up more than 10 years after EVT. Univariate and multivariate subgroup analyses were performed to identify risk factors (midterm MR angiographic results, aneurysm characteristics, retreatment within 5 years).In the prospective study, sac recanalization occurred between midterm and long-term MR angiography in 16 of 129 (12.4%) aneurysms. Grade 2 classification on the Raymond scale at midterm MR angiography (relative risk [RR], 4.16; 99% confidence interval [CI]: 2.12, 8.14) and retreatment within 5 years (RR, 4.67; 99% CI: 1.55, 14.03) were risk factors for late recurrence. In the systematic review (15 cohorts, 2773 patients, 2902 aneurysms), bleeding, aneurysm recurrence, and de novo lesion formation rates were, respectively, 0.7% (99% CI: 0.2%, 2.7%; I(2), 0%; one of 694 patients), 11.4% (99% CI: 7.0%, 18.0%; I(2), 21.6%), and 4.1% (99% CI: 1.7, 9.4%; I(2), 54.1%). Raymond grade 2 initial result (RR, 7.08; 99% CI: 1.24, 40.37; I(2), 82.6%) and aneurysm size greater than 10 mm (RR, 4.37; 99% CI: 1.83, 10.44; I(2), 0%) were risk factors for late recurrence.EVT of intracranial aneurysm is effective for prevention of long-term bleeding, but recurrences occur in a clinically relevant percentage of patients, a finding that may justify follow-up of selected patients for 10 years or more, such as patients with aneurysms larger than 10 mm or classified as Raymond grade 2 at midterm MR angiography.

    View details for DOI 10.1148/radiol.2015142496

    View details for PubMedID 26057784

  • Magnetic resonance imaging at one year for detection of postoperative residual cholesteatoma in children: Is it too early? International journal of pediatric otorhinolaryngology Lecler, A., Lenoir, M., Peron, J., Denoyelle, F., Garabedian, E. N., Pointe, H. D., Nevoux, J. 2015; 79 (8): 1268?74


    To compare the residual cholesteatoma detection accuracy of diffusion-weighted (DW) and T1 delayed sequences for magnetic resonance at one year postoperative with second-look surgery in pediatric patients who have undergone primary middle ear surgery for cholesteatoma.This was a prospective monocentric consecutive study conducted in a tertiary academic referral center. Children were referred for MR imaging (MRI) one year after surgery. A 1.5T MRI was utilized, using nonecho-planar DW images and delayed gadolinium-enhanced T1-weighted images. Accuracy of magnetic resonance imaging was assessed by two radiologists before surgery. Interobserver and intraobserver agreements were assessed using the ? test. Magnetic resonance imaging data were compared with surgery, which was considered as the gold standard.Twenty-four consecutive unselected pediatric patients were included. Sensitivity, specificity, positive predictive value, and negative predictive value for the first observer were of 40%, 86%, 67%, and 67%, respectively, and those for the second observer were 30%, 86%, 60%, and 63%, respectively. The only two cholesteatoma with a size superior to 3mm were diagnosed before surgery, but the majority of small cholesteatoma were not detected.MRI is a key examen to diagnosed the residual cholesteatoma but is limited by the size of the lesion under 3mm. Delaying the realization of MRI during follow-up could increase sensitivity, thus avoiding misdiagnosis as well as unnecessary second look surgery.

    View details for DOI 10.1016/j.ijporl.2015.05.028

    View details for PubMedID 26071017

  • Massive biliary necrosis as a complication of a hereditary hemorrhagic telangiectasia. European journal of gastroenterology & hepatology Lecler, A., Ronot, M., Durand, F., Paradis, V., Vilgrain, V. 2015; 27 (4): 471?74

    View details for DOI 10.1097/MEG.0000000000000309

    View details for PubMedID 25874524

  • Relationship between watershed infarcts and recent intra plaque haemorrhage in carotid atherosclerotic plaque. PloS one Isabel, C., Lecler, A., Turc, G., Naggara, O., Schmitt, E., Belkacem, S., Oppenheim, C., Touzé, E. 2014; 9 (10): e108712


    Watershed infarcts (WSI) are thought to result from hemodynamic mechanism, but studies have suggested that microemboli from unstable carotid plaques may distribute preferentially in watershed areas, i.e., between two cerebral arterial territories. Intraplaque haemorrhage (IPH) is an emerging marker of plaque instability and microembolic activity. We assessed the association between WSI and IPH in patients with recently symptomatic moderate carotid stenosis.We selected 65 patients with symptomatic moderate (median NASCET degree of stenosis = 31%) carotid stenosis and brain infarct on Diffusion-Weighted Imaging (DWI) on Magnetic Resonance Imaging (MRI) from a multicentre prospective study. Fourteen (22%) had WSI (cortical, n = 8; internal, n = 4; cortical and internal, n = 2). Patients with WSI were more likely to have IPH than those without WSI although the difference was not significant (50% vs. 31%, OR = 2.19; 95% CI, 0.66-7.29; P = 0.20). After adjustment for degree of stenosis, age and gender, the results remained unchanged.About one in fifth of brain infarcts occurring in patients with moderate carotid stenosis were distributed in watershed areas. Albeit not significant, an association between IPH--more generally plaque component--and WSI, still remains possible.

    View details for DOI 10.1371/journal.pone.0108712

    View details for PubMedID 25272160

    View details for PubMedCentralID PMC4182714

  • Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology Naggara, O. N., Lecler, A., Oppenheim, C., Meder, J. F., Raymond, J. 2012; 263 (3): 828?35


    To report subgroup analyses of an updated systematic review on endovascular treatment of intracranial unruptured aneurysms (UAs); to compare types of embolic agents, adjunct techniques, and newer devices; and to identify potential risk factors for poor outcomes.Meta-Analysis of Observational Studies in Epidemiology and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were used to prepare this article, and the literature was searched with PubMed and with EMBASE and Cochrane databases. Six eligibility criteria (procedural complications rates; at least 10 patients; saccular, nondissecting UAs; original study published in English or French between January 2003 and July 2011; methodological quality score > 6 [modified Strengthening and Reporting of Observational Studies in Epidemiology criteria]; a study published in a peer-reviewed journal) were used. End points included procedural mortality and unfavorable outcomes (death or modified Rankin Scale, Glasgow Outcome Scale, or World Federation of Neurosurgeons Scale at 1 month scores, all > 2). A fixed-effects model (Mantel-Haenszel) was used for pooled estimates of mortality and unfavorable outcomes; a random-effects model (DerSimonian-Laird) was used in case of heterogeneity.Ninety-seven studies with 7172 patients (26 studies published July 2008 through July 2011) were included. Sixty-nine (1.8%) of 7034 patients died (fixed-effect weighted average; 99% confidence interval [CI]: 1.4%, 2.4%; Q value, 55.0; I(2) = 0%). Unfavorable outcomes, including death, occurred in 4.7% (242 of 6941) of patients (99% CI: 3.8, 5.7; Q value, 128.3; I(2) = 26.8%). Patients treated after 2004 had better outcomes (unfavorable outcome, 3.1; 99% CI: 2.4, 4.0) than patients treated during 2001-2003 (unfavorable outcome, 4.7%; 99% CI: 3.6%, 6.1%; P = .01) or in 2000 and before (unfavorable outcome, 5.6%; 99% CI: 4.7%, 6.6%; P < .001). Significantly higher risk was associated with liquid embolic agents (8.1%; 99% CI: 4.7%, 13.7%) versus simple coil placement (4.9%; 99% CI: 3.8%, 6.3%; P = .002). Unfavorable outcomes occurred in 11.5% (99% CI: 4.9%, 24.6%) of patients treated with flow diversion.Procedure-related poor outcomes occurred (4.7% of patients), risks decreased, and liquid embolic agents and flow diversion were associated with higher risks.

    View details for DOI 10.1148/radiol.12112114

    View details for PubMedID 22623696

  • Quality indicators for colonoscopy procedures: a prospective multicentre method for endoscopy units. PloS one Coriat, R., Lecler, A., Lamarque, D., Deyra, J., Roche, H., Nizou, C., Berretta, O., Mesnard, B., Bouygues, M., Soupison, A., Monnin, J. L., Podevin, P., Cassaz, C., Sautereau, D., Prat, F., Chaussade, S. 2012; 7 (4): e33957


    Healthcare professionals are required to conduct quality control of endoscopy procedures, and yet there is no standardised method for assessing quality. The topic of the present study was to validate the applicability of the procedure in daily practice, giving physicians the ability to define areas for continuous quality improvement.In ten endoscopy units in France, 200 patients per centre undergoing colonoscopy were enrolled in the study. An evaluation was carried out based on a prospectively developed checklist of 10 quality-control indicators including five dependent upon and five independent of the colonoscopy procedure.Of the 2000 procedures, 30% were done at general hospitals, 20% at university hospitals, and 50% in private practices. The colonoscopies were carried out for a valid indication for 95.9% (range 92.5-100). Colon preparation was insufficient in 3.7% (range 1-10.5). Colonoscopies were successful in 95.3% (range 81-99). Adenoma detection rate was 0.31 (range 0.17-0.45) in successful colonoscopies.This tool for evaluating the quality of colonoscopy procedures in healthcare units is based on standard endoscopy and patient criteria. It is an easy and feasible procedure giving the ability to detect suboptimal practice and differences between endoscopy-units. It will enable individual units to assess the quality of their colonoscopy techniques.

    View details for DOI 10.1371/journal.pone.0033957

    View details for PubMedID 22509267

    View details for PubMedCentralID PMC3324486

  • Flexible sigmoidoscopy: an archaic tool for 40-50-year-old patients with fresh bleeding per rectum. Endoscopy Barret, M., Coriat, R., Lecler, A., Deyra, J., Prat, F., Chaussade, S. 2012; 44 (2): 217

    View details for DOI 10.1055/s-0030-1257047

    View details for PubMedID 22271033

  • Focal nodular hyperplasia. Clinics and research in hepatology and gastroenterology Lecler, A., Arrivé, L. 2011; 35 (3): 159?60

    View details for DOI 10.1016/j.clinre.2010.10.006

    View details for PubMedID 21398200

Footer Links:

Stanford Medicine Resources: